<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03380052</url>
  </required_header>
  <id_info>
    <org_study_id>B-1610/368-106</org_study_id>
    <nct_id>NCT03380052</nct_id>
  </id_info>
  <brief_title>OLGA and OLGIM Stage System for Gastric Cancer</brief_title>
  <official_title>The Evaluation of OLGA and OLGIM Stage Systems for Prediction of Gastric Cancer Risk and Interaction With Other Risk Factors According to Lauren's Classification</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Clinical Research Coordination Center, Seoul, Korea</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Seoul National University Bundang Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To validate OLGA and OLGIM staging system for estimating GC risk according to Lauren's
      histologic classification in South Korea. Also attempted to estimate synergistic interaction
      among the several risk factors to help establish surveillance strategy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To validated the OLGA and OLGIM staging system to estimate gastric cancer risk according to
      Lauren's histologic classification in South Korea, where the incidence rate of GC is high. In
      addition, the investigators attempted to investigate the interaction among the several risk
      factors including OLGA or OLGIM staging system for the risk of GC to help establish
      surveillance strategy.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 2006</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The evaluation of OLGA and OLGIM stage systems for prediction of gastric cancer risk</measure>
    <time_frame>per 1 year</time_frame>
    <description>To validate OLGA and OLGIM staging system for estimating GC risk according to Lauren's histologic classification</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">3000</enrollment>
  <condition>Stomach Neoplasms</condition>
  <condition>Atrophic Gastritis</condition>
  <condition>Intestinal Metaplasia</condition>
  <arm_group>
    <arm_group_label>Gastric cancer</arm_group_label>
    <description>Patients who were diagnosed with gastric cancer</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Healthy participants or benign disease patients such as benign gastric ulcers, duodenal ulcers, reflux esophagitis, or non-erosive reflux disease</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who visited gastroenterology department complaining of gastrointestinal symptoms
        and underwent esophagogastroduodenoscopy (EGD)
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Control group

               -  those who were between 25 and 80 years old and did not have any evidence of
                  gastric cancer and gastric dysplasia, esophageal tumor and MALToma in upper
                  gastrointestinal endoscopy

          -  Gastric cancer group

               -  Patients diagnosed as gastric cancer in the upper gastrointestinal endoscopy at
                  the time of participating in the study between 25 and 80 years old.

        Exclusion Criteria:

          -  history of previous gastrointestinal surgery,

          -  any other malignancy

          -  cardia cancer

          -  who do not perform endoscopic biopsy

          -  pathologically proven gastric dysplasia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Officials Officials, Officials</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Bundang Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nayoung Kim, Professor</last_name>
    <phone>+82-31-787-7008</phone>
    <email>nayoungkim49@empas.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam-si</city>
        <state>Gyeonggi-do</state>
        <zip>463-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Nayoung Kim, M.D.,Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 16, 2017</study_first_submitted>
  <study_first_submitted_qc>December 16, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 20, 2017</study_first_posted>
  <last_update_submitted>December 20, 2017</last_update_submitted>
  <last_update_submitted_qc>December 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Bundang Hospital</investigator_affiliation>
    <investigator_full_name>Nayoung Kim</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>OLGA</keyword>
  <keyword>OLGIM</keyword>
  <keyword>Helicobacter pylori</keyword>
  <keyword>Gastric cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
    <mesh_term>Gastritis</mesh_term>
    <mesh_term>Metaplasia</mesh_term>
    <mesh_term>Gastritis, Atrophic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

